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Primary Intracranial Neoplasms. J. HOL-
LENBERG and D. H. FORD (1980) Lancaster:
MTP Medical & Scientific Books. 174 pp.
£1050.
This book consists of papers presented at a
symposium on primary brain tumours, and is
sponsored by the Brooklyn Unit ofthe Ameri-
can Cancer Society. The papers presented
deal with different aspects of primary intra-
cranial neoplasms. H. M. Zimmerman in the
first paper discusses the role of experimental
models of brain tumours, and the ways in
which these can be induced, using higher
aromatic hydrocarbons, resorptive carcino-
gens and viruses. The second paper, by H. S.
Schutta, describes the clinical problems asso-
ciated with the diagnosis ofgliomas, mainly in
adults. J. B. Cracco follows with a paper on
brain tumours in childhood and their clinical
presentation, which he summarises very
succinctly. A. R. Butler describes the excel-
lent diagnostic ability of the C.T. scan in
supratentorial glioma, in which 100% accu-
racy of diagnosis is possible. M. S. Tenner
examines the part now remaining for con-
ventional neuroradiological techniques, which
can still be used for information that is not
always available from a C.T. scan alone. It is
good to be reminded that new techniques are
not a replacement for the old, but are to be
added for more information, and that both
old and new will give best results in the right
circumstances. P. M. Farmer spoke on the
value of electron microscopy in the histo-
logical diagnosis and differentiation of brain
tumours, illustrating his points with several
individual cases. The cytology of the CSF
in brain tumours and diagnosis from this is
described by J. Hollenberg Sher, with
examples ofwhat the cytologist has on which
to make his diagnosis. W. A. Shucart des-
cribes very frankly the problems ofsurgery in
brain tumours, and makes the most important
point that even when complete removal is
barely possible, removal of the bulk of the
tumour increases the chances of success with
other modes oftreatment. These other modes
of radiation and chemotherapy are discussed
in the last paper, by W. Shapiro, and the
results of the Brain Tumour Study Group
trial of the nitrosoureas versus radiation and
nitrosoureas in malignant glioma are pre-
sented.
Some of the papers in this symposium are
quite interesting, but if a study in depth of
brain tumours was the reader's need, this
collection is only a tiny part of all that could
be written, and most ofit is very superficial.
D. PEARSON
Medical Oncology: An Advanced Course.
J. G. SINKOVICS (1979) New York: Marcel
Dekker Inc. 679 pp.
Unlike the present situation in Great
Britain, medical oncologists in the United
States and other countries arerequired topass
subspecialty board examinations in medical
oncology,haematologyandinfectiousdiseases.
Whatever the merits or demerits of this sys-
tem, it is inevitable that recommended texts
willappear, forpreparationfortheseexamina-
tions.
There have been many new textbooks of
Medical Oncology published in the past few
years, of varying quality. This latest volume
by Joseph G. Sinkovics directs itself speci-
ficallyto aidfellows andresidents inadvanced
training to prepare for this Subspecialty
Board examination and has as an appendix
a large number of multiple-choice assessment
questions. The book is relatively short for a
comprehensive textbook ofmedical oncology,
and to compensate for this the style is often
almost telegraphic, as the author admits.
Unfortunately, in some instances, this has led
to sections being almost incomprehensible.
Also, because of the need for brevity, a
balanced view of controversies in the treat-
ment of cancer is not always possible, and
although the different arguments are stated
and the relevant references given, no weight-
ing or balanced opinion is offered in many
circumstances. An example of this can be
seen in a discussion of surgery for carcinoma
ofthe breast, which states that reconstructive
surgery is essential after mastectomy and the
nipple, if tumour free, should be grafted to
the groin for latertransplantation. This would
not be regarded as standard practice in all
centres! A useful section of the book is the250 BOOK REVIEWS
review of infectious complications of malig-
nant disease and in the treatment of malig-
nant disease. This is thorough and the dif-
ferent infections are arranged to stress their
relevant importance.
The self-assessment questions are compre-
hensive and, in most cases, pose valid and
relevant questions. Some questions, however,
do not appear to have a definite answer, and
it is to be hoped that the American Sub-
specialty Boards allow for discussion of con-
troversies in medical oncology in which a
simple true-or-false or multiple-choice answer
is inappropriate.
Insummary, this bookrepresents a massive
accumulation of data and information. It
cannot, however, be fully recommended,
because of its, at times, incomprehensible
styleanditslackofspacetodiscussobjectively
different treatment options available for
many of the diseases in which chemotherapy
is used.
D. CROWTHER
Molecular and Cellular Aspects of Car-
cinogen Screening Tests. Eds R. MoN-
TESANO, H. BARTSCH, L. TOMATIS (1980)
Lyons: WHO-IARC. 371 pp. US$40-00,
Sw. Fr. 60.
Some ofthe newer information on responses
of a variety of short-term tests to mutagens
and carcinogens are presented in this volume,
and it is evident that a more critical and
analytical approach to the vast amount of
data being generated is now being adopted.
Much more emphasis is now being placed on
understanding the scientific basis for the
various short-term tests. There is also a shift
of emphasis from an exclusive consideration
of tests which will detect only initiators to
those which will detect promoters and will
respond to epigenetic effects now being re-
considered as possibly involved in carcino-
genesis; this new approach being exemplified
by the contribution from Radman and his
co-workers.
The interesting section on the scientific
basis for short-term tests includes a pertinent
paper from Green (Sussex) in which the prob-
lems ofusing the Ames test as even a qualita-
tive index of carcinogenicity are discussed;
the main problem being how to define a
positive result. When attempts are made to
use even the well-validated Ames test quanti-
tatively (i.e. to attempt correlations ofmuta-
genic potency with carcinogenic potency) the
problems are compounded, and these are
lucidly discussed in this paper.
Other papers in the volume deal with inter-
laboratory reproducibility of various tests,
attempts at a classification of experimental
evidence to indicate degrees of carcinogeni-
city, and details of various international
collaborative schemes for mutagenicity and
carcinogenicity. Overall, a useful update of
progress in this rapidly expanding field.
M. Fox
Therapeutic Progress in Ovarian Cancer,
Testicular Cancer and the Sarcomas.
Ed. A. T. VAN OOSTEROM, F. M. MIUGGIA &
F. J. CLETON (1980) The Netherlands:
Leiden University. 507 pp. 124 Guilders.
In the last decade, there has been evidence
ofa gradual reduction in deaths due to cancer
in the under-45 age group. This decrease in
the younger age group can be in part attribu-
ted to the use of chemotherapy in such dis-
orders as osteosarcoma, ovarian cancer,
Hogkin's disease and acute lymphoblastic
leukaemia. Of all the newer methods of
treatmentofmalignantdisease, chemotherapy
in solid malignant tumours is one ofthe most
promising.
The 16th Boerhaave course organized by
the Faculty of Medicine, University of
Leiden, Netherlands, and the Page and
William Black Postgraduate School of Medi-
cine, Mount Sinai School of Medicine, New
York, U.S.A., was held in December 1979.
The proceedings ofthis course have now been
published by the Leiden University Press,
and the editors are to be congratulated on its
rapid production. The proceedings are a
collection of 31 original papers presented at
the course, covering ovarian cancer, testicular
cancer, osteosarcoma and the soft-tissue
sarcomas. In addition, each part ends with a
panel discussion on current and future
management.
In view ofthe acknowledged poor prognosis
of these particular tumours, this book is a
timely and important reminder that progress
in the management ofthese diseases is occur-
ring. In each section, the importance of
primary surgical treatment, accurate staging,
and the use of both adjuvant and primary
chemotherapy are stressed. Up-to-date re-